Drug-resistant breast cancer cells are dependent on GPX4 and SLC7A11, which means they are vulnerable to ferroptosis caused by GPX4 and SLC7A11 inhibition (Hangauer et al., 2017). Here, SLC7A11 is linked to breast cancer.